论文信息 - Tumor metabolic volume by 18F-FDG-PET as a prognostic predictor of first-line pembrolizumab for NSCLC patients with PD-L1 ≥ 50% - 字舞流文

Tumor metabolic volume by 18F-FDG-PET as a prognostic predictor of first-line pembrolizumab for NSCLC patients with PD-L1 ≥ 50%

Kunihiko Kobayashi | K. Kaira | H. Kagamu | O. Yamaguchi | I. Kuji | A. Mouri | Y. Murayama | A. Shiono | K. Hashimoto | Y. Miura | K. Kobayashi